SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-128739
Filing Date
2018-04-24
Accepted
2018-04-24 16:03:28
Documents
10
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 S-3ASR d573964ds3asr.htm S-3ASR 299939
2 EX-4.3 d573964dex43.htm EX-4.3 309926
3 EX-4.5 d573964dex45.htm EX-4.5 97903
4 EX-4.6 d573964dex46.htm EX-4.6 102596
5 EX-4.7 d573964dex47.htm EX-4.7 84806
6 EX-5.1 d573964dex51.htm EX-5.1 24162
7 EX-12.1 d573964dex121.htm EX-12.1 18008
8 EX-23.1 d573964dex231.htm EX-23.1 1719
9 GRAPHIC g573964g85h57.jpg GRAPHIC 43168
10 GRAPHIC g573964g87s46.jpg GRAPHIC 3448
  Complete submission text file 0001193125-18-128739.txt   1004588
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-224418 | Film No.: 18771471
SIC: 2836 Biological Products, (No Diagnostic Substances)